Bicocca Open Archive

Logo unimib boa
SERAVALLE, GINO LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.583
AS - Asia 2.918
EU - Europa 2.659
SA - Sud America 516
AF - Africa 58
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.482
SG - Singapore 1.131
CN - Cina 702
HK - Hong Kong 569
RU - Federazione Russa 562
DE - Germania 540
BR - Brasile 405
IT - Italia 366
IE - Irlanda 324
SE - Svezia 298
VN - Vietnam 231
GB - Regno Unito 137
AT - Austria 105
UA - Ucraina 82
FR - Francia 66
CA - Canada 63
IN - India 54
ID - Indonesia 52
AR - Argentina 46
FI - Finlandia 44
KR - Corea 39
DK - Danimarca 29
MX - Messico 28
ZA - Sudafrica 27
JP - Giappone 26
EC - Ecuador 25
TR - Turchia 24
PL - Polonia 23
BD - Bangladesh 18
NL - Olanda 16
ES - Italia 15
BE - Belgio 14
CO - Colombia 11
IQ - Iraq 11
PK - Pakistan 10
CL - Cile 8
SA - Arabia Saudita 8
AU - Australia 7
VE - Venezuela 7
BG - Bulgaria 6
EG - Egitto 6
PE - Perù 6
PH - Filippine 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
MK - Macedonia 5
PY - Paraguay 5
SN - Senegal 5
EU - Europa 4
IR - Iran 4
NZ - Nuova Zelanda 4
CH - Svizzera 3
DZ - Algeria 3
LK - Sri Lanka 3
LT - Lituania 3
MA - Marocco 3
NG - Nigeria 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BJ - Benin 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
MU - Mauritius 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.751
Salva come PNG Salva come JPEG
Città #
Ann Arbor 877
Singapore 662
Hong Kong 565
Fairfield 495
Ashburn 447
Frankfurt am Main 402
Chandler 316
Dublin 313
Wilmington 257
Woodbridge 221
Houston 213
Seattle 208
New York 189
Dallas 172
Dearborn 139
Milan 131
Princeton 130
Beijing 126
Cambridge 124
Santa Clara 103
Vienna 96
Los Angeles 89
Hefei 81
Moscow 75
Jacksonville 72
Ho Chi Minh City 68
Altamura 58
Lawrence 56
Nanjing 49
Shanghai 44
Buffalo 42
Hanoi 38
São Paulo 37
The Dalles 36
Jakarta 35
Chicago 34
Seoul 34
Dong Ket 33
San Diego 33
Council Bluffs 31
Munich 30
London 24
Lissone 23
Guangzhou 21
Boardman 20
Helsinki 20
Andover 19
Salt Lake City 19
Toronto 19
Atlanta 18
Nanchang 17
Tokyo 17
Montreal 16
Kunming 15
Warsaw 15
Brooklyn 13
Jiaxing 13
Shenyang 13
Brussels 12
Changsha 12
Columbus 12
Poplar 12
San Francisco 12
Tianjin 12
Belo Horizonte 11
Haiphong 11
Rio de Janeiro 11
Jinan 10
Quito 10
Hebei 9
Nuremberg 9
Da Nang 8
Falls Church 8
Johannesburg 8
Lappeenranta 8
Phoenix 8
Turku 8
Bexley 7
Brasília 7
Edmonton 7
Hangzhou 7
Lachine 7
Monza 7
Mumbai 7
Orem 7
Pune 7
Sacramento 7
Bologna 6
Bonndorf 6
Chennai 6
Concorezzo 6
Copenhagen 6
Düsseldorf 6
Esslingen am Neckar 6
Norwalk 6
Quận Bình Thạnh 6
Stockholm 6
Tashkent 6
Zhengzhou 6
Akatsuka-shinmachi 5
Totale 7.801
Salva come PNG Salva come JPEG
Nome #
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 294
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 281
Heart rate as cardiovascular risk factor 277
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 267
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 244
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 238
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 236
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 234
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 234
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 231
Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights 226
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 220
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 213
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 211
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 206
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 204
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 198
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 195
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 191
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 190
Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure 189
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 184
Sympathetic Nervous System, Hypertension, Obesity and Metabolic Syndrome 174
Effects of Renal Denervation on Sympathetic Nervous System Activity 168
Baroreflex activation therapy systems: current status and future prospects 164
The role of carotid baroreceptor stimulation 163
Sympathetic activation in cardiovascular disease: Evidence, clinical impact and therapeutic implications 159
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 156
The role of brain in neurogenic prehypertension 152
Blood pressure measurement, white-coat and masked hypertension 149
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 148
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 147
Sympatho-Vagal Imbalance in Hypertension 146
Age- and sex-specific reference values for media/lumen ratio in small arteries and relationship with risk factors 145
Sympathetic Nervous System, Sleep, and Hypertension 140
Elevated heart rate as sympathetic biomarker in human obesity 136
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 135
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 134
Heart rate as a predictor of cardiovascular risk 133
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 133
Obesity and Hypertension 132
Obesity and hypertension 131
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS) 127
Association between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers 127
Assessment of heart rate as 'sympathetic biomarker': Strengths and pitfalls 127
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis 124
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 121
Treatment of resistant hypertension 121
Cardiopulmonary receptor and arterial baroreceptor reflexes after acute myocardial infarction 120
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 120
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 118
Lercanidipine in the management of hypertension: An update 118
New-onset aortic dilatation in the population: a quarter-century follow-up 116
Cigarette smoking and the adrenergic nervous system 114
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea 113
Sleep Apnea and Hypertension 112
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension 110
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 109
Targeting persistent normal left ventricular geometry in the general population: a 25-year follow-up study 109
Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part A: Mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment 107
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 106
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 105
Cardiovascular physiology: regulation of blood pressure 103
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 103
Neurohormonal interactions 103
The Complex Relationship Between Serum Uric Acid, Endothelial Function and Small Vessel Remodeling in Humans 102
Neural Mechanisms 101
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 99
Arterial alterations in hypertension 98
Device-Based Treatment in Hypertension and Heart Failure 95
Iatrogenic Aspects of sports cardiology and lifestyle modifications, Chapter 25: Trained Athletes 94
Clinical relevance of the sympathetic–vascular interactions in health and disease 94
Sympathetic Activity in Hypertension and Heart Failure 91
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 91
Corrigendum to “Obesity and hypertension” [Pharmacological Research 122 (2017) 1–7](S1043661817304620)(10.1016/j.phrs.2017.05.013) 88
Microvascular Alterations in Obesity 86
Baroreceptor Stimulation 86
Visit-to-visit blood pressure variability is related to sympathetic neural drive and baroreflex sensitivity in hypertensive patients 83
Trained Athletes 82
Sympathomodulation in congestive heart failure: From drugs to devices 80
Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload 77
The sympathetic nervous system in hypertension 69
ASSOCIATION BETWEEN HEART RATE TRESHOLDS FOR CARDIOVASCULAR RISK DEFINED BY NEW ESC/ESH GUIDELINES AND NEUROADRENERGIC MARKERS 63
Totale 12.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 0 108 160 158 116 115 87 126
2021/2022970 81 87 106 57 75 64 64 56 41 89 77 173
2022/20231.521 169 421 170 135 96 250 28 66 100 17 48 21
2023/20241.082 30 34 46 107 155 278 173 25 100 17 16 101
2024/20252.531 150 318 112 92 196 97 169 107 242 372 269 407
2025/20262.717 519 310 489 665 653 81 0 0 0 0 0 0
Totale 12.120